Recent

% | $
Quotes you view appear here for quick access.

Allergan plc Message Board

  • fastestgrowingstocks fastestgrowingstocks Feb 8, 2012 7:31 PM Flag

    REPCF discovers cure for baldness..serious. check it out

    http://www.greenbackers.com/blog/index.php


    Wednesday, February 01, 2012

    .: Followup to REPCF cure for baldness. Interview with CEO :.

    NBT Two-Minute Drill Interview with David Hall, CEO of Replicel Life Sciences




    We recently interviewed David Hall, CEO of Replicel Life Sciences, Inc., on the upcoming Phase I/IIa clinical trial results “reveal” for their cell-based hair regeneration technology some 90 or so days away.




    With positive results expected from their current Phase I/IIa trial, Replicel will move immediately into a 100-patient dosing trial from which it hopes to build an overwhelming set of successful data for the patented RepliCel™ procedure for minimally invasive hair cell growth and implantation.




    With two successful data-sets in hand, Replicel intends to sell its entire hair growth and implantation business to the highest Big Pharma/Big Bio bidder. NBT analyses the value of their follicular regeneration business at about $500 million—or more than $10 a share with an expected 10 million share dilution from money raising activities in 2012.

    ....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Well, is it a cure or a treatment for baldness?

      Plus, you state: "With positive results expected from their current Phase I/IIa trial..."
      This is very a speculative play -- early stage of development -- for a treatment that borrows from -- and reminds folks of -- Fibrocell's "Laviv" -- the only autologous cell treatment in the known universe.

      Me think AGN's baldness treatment -- for it's proven efficacy -- is perhaps further down the road on the clinical track.

 
AGN
308.01-3.99(-1.28%)Aug 28 4:01 PMEDT